Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype

被引:66
作者
Senat, MV
De Keersmaecker, B
Audibert, F
Montcharmont, G
Frydman, R
Ville, Y
机构
[1] CHU Clamart, Dept Obstet & Gynecol, Clamart, France
[2] CHI Poissy, Dept Obstet & Gynecol, Poissy, France
关键词
nuchal translucency; normal karyotype;
D O I
10.1002/pd.321
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective: This study was conducted to evaluate pregnancy outcome and mid- and long-term prognosis of cases with nuchal translucency greater than or equal to4 mm and normal karyotype. Methods Retrospective analysis of 160 cases who presented with a nuchal translucency greater than or equal to4 mm when the CRL was between 45 and 84 mm was undertaken. Cystic hygromas were excluded. When the karyotype was normal a detailed anomaly scan was performed at 20 to 24 weeks followed by serial ultrasound examination. Clinical examination of the neonates was performed by a paediatrician. Long-term follow-up was completed through a questionnaire filled in by parents, GPs and paediatricians. Results 160 fetuses had an NT greater than or equal to 4 mm. 44.3% had an abnormal karyotype. Of the 55.7% with normal karyotypes, 74% did not show any abnormalities on follow-up ultrasound scan. Mid- and long-term outcome was known in 91% of the cases, 6.4% had a malformation diagnosed only at birth. Among the normal neonates, 11.1% are considered to have a significant neurological handicap or orthopaedic problems at 12 to 72 months of age. Conclusion In an unselected population, NT greater than or equal to4 mm is associated with a high incidence of chromosomal and non chromosomal abnormalities, Even when the fetal karyotype and serial ultrasound examinations are considered to be normal, the risk of fetal malformation and developmental delay should not be underestimated. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 15 条
[1]   Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population [J].
Adekunle, O ;
Gopee, A ;
El-Sayed, M ;
Thilaganathan, B .
BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (857) :457-460
[2]   Outcome of fetuses with enlarged nuchal translucency and normal karyotype [J].
Bilardo, CM ;
Pajkrt, E ;
de Graaf, I ;
Mol, BW ;
Bleker, OP .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 11 (06) :401-406
[3]  
Chaban FK, 1996, PRENATAL DIAG, V16, P537, DOI 10.1002/(SICI)1097-0223(199606)16:6<537::AID-PD911>3.0.CO
[4]  
2-4
[5]   Fetal nuchal translucency and normal chromosomes: a long-term follow-up study [J].
Hiippala, A ;
Eronen, M ;
Taipale, P ;
Salonen, R ;
Hiilesmaa, V .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (01) :18-22
[6]   Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study [J].
Hyett, J ;
Perdu, M ;
Sharland, G ;
Snijders, R ;
Nicolaides, KH .
BRITISH MEDICAL JOURNAL, 1999, 318 (7176) :81-85
[7]  
MALVRIDES E, 2001, ULTRASOUND OBST GYN, V17, P106
[8]   Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses [J].
Michailidis, GD ;
Economides, DL .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (02) :102-105
[9]   Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population [J].
Pajkrt, E ;
Mol, BWJ ;
van Lith, JMM ;
Bleker, OP ;
Bilardo, CM .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 12 (03) :156-162
[10]   Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation [J].
Pandya, PP ;
Snijders, RJM ;
Johnson, SP ;
Brizot, MD ;
Nicolaides, KH .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (12) :957-962